Innovation
By providing robust human cell-based translational models, Nodality can answer questions that have remained unanswered by other technologies and enable transformative therapies.
Creating Value Solutions for Drug Developers What Differentiates NodalityCollaboration
Nodality provides high quality customized services and products to drug developers to solve the challenges encountered at any stage of drug discovery and development.
Working with Nodality Our Collaborations Proven Benefits of CollaborationTechnology
Nodality’s industry-leading technology – Single Cell Network Profiling (SCNP™) – is a multiparametric flow cytometry platform that provides robust human cell-based translational models of disease, drug action and patient-specific response.
Single Cell Network Profiling Analysis and Visualization Robust and ReproducibleRecent News
Feb 25, 2015 Nodality, Inc. Presents Data from Immuno-Oncology Program Applying Company’s Novel SCNP™ Platform. Read More
Jan 07, 2015 Nodality Launches PathPro™ Product Line to Enhance Pharmaceutical R&D. Read More
Nov 19, 2014 Nodality Develops Disease-Associated PD-1 Assay System for Application in Immuno-oncology. Read More